{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:36:30Z","timestamp":1785800190896,"version":"3.56.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.2416","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T15:32:43Z","timestamp":1555687963000},"page":"e192416","source":"Crossref","is-referenced-by-count":29,"title":["Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation"],"prefix":"10.1001","volume":"2","author":[{"given":"Alma B.","family":"Pedersen","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe","family":"Heide-J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik T.","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Prieto-Alhambra","sequence":"additional","affiliation":[{"name":"Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"},{"name":"Grup de Recerca en Epidemiologia de las Malalties Prevalents de l\u2019Aparell Locomotor Research Group, Centro de Investigaci\u00f3n Biom\u00e9dica en Red Fragilidad y Envejcimiento Saludable (CIBERFes), Instituto de Salud Carlos III and Universitat Autonoma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ehrenstein","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"issue":"8","key":"zoi190107r1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis.","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"issue":"1-2","key":"zoi190107r2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"issue":"14","key":"zoi190107r3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMcp071112","article-title":"Clinical practice: osteoarthritis of the hip.","volume":"357","author":"Lane","year":"2007","journal-title":"N Engl J Med"},{"issue":"6914","key":"zoi190107r4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/bmj.307.6914.1248","article-title":"Mortality and morbidity after hip fractures.","volume":"307","author":"Keene","year":"1993","journal-title":"BMJ"},{"key":"zoi190107r5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bone.2014.02.016","article-title":"Mortality following the first hip fracture in Norwegian women and men (1999-2008): a NOREPOS study.","volume":"63","author":"Omsland","year":"2014","journal-title":"Bone"},{"issue":"425","key":"zoi190107r6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.blo.0000132404.30139.f2","article-title":"Osteoporosis: a review.","author":"Lin","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"zoi190107r7","doi-asserted-by":"publisher","first-page":"h3783","DOI":"10.1136\/bmj.h3783","article-title":"Bisphosphonates for the prevention and treatment of osteoporosis.","volume":"351","author":"Maraka","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"zoi190107r8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women.","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"4","key":"zoi190107r10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects.","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"issue":"8","key":"zoi190107r11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi190107r12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","article-title":"Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women.","volume":"23","author":"Freemantle","year":"2012","journal-title":"Osteoporos Int"},{"issue":"3","key":"zoi190107r13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00198-010-1424-x","article-title":"Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis.","volume":"22","author":"J\u00f6nsson","year":"2011","journal-title":"Osteoporos Int"},{"issue":"5","key":"zoi190107r14","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00198-017-3940-4","article-title":"Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.","volume":"28","author":"Mori","year":"2017","journal-title":"Osteoporos Int"},{"issue":"2","key":"zoi190107r15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.afos.2016.03.003","article-title":"Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis.","volume":"2","author":"Benjamin","year":"2016","journal-title":"Osteoporos Sarcopenia"},{"issue":"4","key":"zoi190107r16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/ijcp.2012.66.issue-4","article-title":"Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis.","volume":"66","author":"Lin","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"8837","key":"zoi190107r17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures.","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet"},{"issue":"7041","key":"zoi190107r18","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"issue":"8","key":"zoi190107r19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology.","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"zoi190107r20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/CLEP","article-title":"Existing data sources for clinical epidemiology: the Danish National Database of Reimbursed Prescriptions.","volume":"4","author":"Johannesdottir","year":"2012","journal-title":"Clin Epidemiol"},{"key":"zoi190107r21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential.","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"4","key":"zoi190107r22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics.","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"zoi190107r23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jclinepi.2012.10.004","article-title":"The validity of administrative data to identify hip fractures is high: a systematic review.","volume":"66","author":"Hudson","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"zoi190107r24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/pds.v26.8","article-title":"Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong.","volume":"26","author":"Sing","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"zoi190107r25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson Comorbidity Index conditions in the population-based Danish National Registry of Patients.","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"zoi190107r26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"issue":"10","key":"zoi190107r27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.","volume":"46","author":"Romano","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"28","key":"zoi190107r28","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.v34.28","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"1","key":"zoi190107r29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1359\/jbmr.2009.24.issue-1","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"1","key":"zoi190107r30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy.","volume":"25","author":"Kendler","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"12","key":"zoi190107r31","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1359\/jbmr.070809","article-title":"Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.","volume":"22","author":"Lewiecki","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"8","key":"zoi190107r32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density.","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi190107r33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/AOG.0b013e318291718c","article-title":"Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial.","volume":"121","author":"Recknor","year":"2013","journal-title":"Obstet Gynecol"},{"key":"zoi190107r34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","article-title":"Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.","volume":"58","author":"Roux","year":"2014","journal-title":"Bone"},{"issue":"10","key":"zoi190107r35","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/jbmr.v31.10","article-title":"Hip fracture in patients with non-dialysis-requiring chronic kidney disease.","volume":"31","author":"Kim","year":"2016","journal-title":"J Bone Miner Res"},{"key":"zoi190107r9","unstructured":"European Medicines Agency.Prolia (denosumab). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/prolia. Accessed March 6, 2019."},{"key":"zoi190107r36","unstructured":"National Institute for Health and Care Excellence. Denosumab for the prevention of osteoporotic fractures in postmenopausal women. https:\/\/nice.org.uk\/guidance\/ta204. Accessed November 5, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/2\/4\/e192416\/17478478\/pedersen_2019_oi_190107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T15:32:54Z","timestamp":1555687974000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2019.2416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.2416","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]}}}